UBS cuts Under Armour stock price target on longer turnaround By Investing.com

Under Armour’s FY2027 EPS guidance of $0.08-$0.12 fell well below the $0.23 Street estimate, prompting multiple analyst target cuts. UBS trimmed its price target to $10 from $11 while keeping a Buy rating, but Truist, Telsey, BofA, and Stifel all lowered targets amid concerns about slower turnaround progress, North American weakness, and higher costs. Shares fell 17% after the report and are down 20% over the past week.

Analysis

The market is now pricing UAA less like a near-term earnings story and more like a long-duration optionality asset. That creates a classic “bad news gets smaller over time” setup: if management can keep gross margin erosion contained while cost actions compound, the stock can re-rate long before the income statement fully inflects. The key second-order effect is that every quarter of delay increases the probability the turnaround is financed by margin sacrifice rather than revenue acceleration, which usually compresses multiple expansion but can still set up a sharp reflexive rally if expectations reset enough.

The biggest beneficiary is likely not another branded-apparel name but the value channel and discount retailers that capture share while UAA rationalizes its go-to-market. If the brand’s product mix shifts toward fewer but higher-quality launches, the near-term loser is inventory-heavy wholesale partners that need traffic-driving freshness; that can create a temporary air pocket in orders before the cleaner assortment shows up in sell-through. Competitors with stronger pricing power may actually see a short-term read-through that the category remains promotional, limiting margin optimism across athletic apparel.

The contrarian case is that consensus may be underestimating how much of the downside is already in the equity, but overestimating the speed of fundamental normalization. At this price, a modest stabilization in North America and one or two quarters of cleaner expense cadence can drive a disproportionate move because the equity value is so small relative to any credible mid-cycle earnings power. The risk is that guidance turns into a multi-year slog: if sales keep lagging while restructuring costs persist, the stock can stay a value trap and drift lower in slow motion rather than collapse further.

For timing, the best setup is probably not before the next quarter, but after the market gets another data point on whether the reset is improving sell-through and inventory health. A durable turn would likely show up first in margin and working-capital metrics, not top-line growth, so the catalyst window is 1-2 quarters rather than days. If those metrics fail, the bear case becomes structurally stronger because the current valuation leaves little room for another disappointment.

Key Decisions for Investors

• Long UAA as a tactical mean-reversion trade only on confirmation of inventory cleanup and gross-margin stabilization over the next 1-2 quarters; downside is capped by already-discounted expectations, upside is a sharp re-rating if execution improves.
• Use call spreads on UAA instead of common stock for a defined-risk expression over 3-6 months; the thesis is multiple expansion on lowered expectations, with risk limited if the turnaround drifts.
• Pair trade: long UAA / short a stronger athletic-apparel peer basket if you believe the market is overpaying for near-term growth quality and missing the optionality in a beaten-up turnaround.
• Avoid adding ahead of another guidance reset; if upcoming quarterly sell-through data weakens, the stock can reprice lower in a slow bleed over the next 1-2 quarters despite the low absolute price.
• For more defensive capital, wait for evidence of positive operating leverage before sizing a long; the risk/reward improves materially only when the market can underwrite a 12-18 month earnings inflection rather than just a valuation floor.